MORGAN STANLEY - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 348 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$80,958,886
+7.9%
5,233,281
+9.5%
0.01%
+14.3%
Q2 2023$75,055,387
-0.6%
4,777,552
+4.3%
0.01%
-12.5%
Q1 2023$75,487,489
+7.0%
4,580,551
+1.3%
0.01%0.0%
Q4 2022$70,565,659
+17.7%
4,523,439
-2.2%
0.01%0.0%
Q3 2022$59,961,000
+0.6%
4,623,007
+8.9%
0.01%0.0%
Q2 2022$59,583,000
+1187.7%
4,243,825
+1213.2%
0.01%
+700.0%
Q1 2022$4,627,000
-51.5%
323,178
-53.9%
0.00%0.0%
Q4 2021$9,549,000
-70.0%
700,611
-64.0%
0.00%
-75.0%
Q3 2021$31,842,000
-6.6%
1,943,963
-4.1%
0.00%0.0%
Q2 2021$34,104,000
-13.0%
2,026,382
-5.6%
0.00%
-33.3%
Q1 2021$39,208,000
+9.7%
2,147,183
+9.4%
0.01%0.0%
Q4 2020$35,737,000
-0.7%
1,963,542
-2.7%
0.01%
-14.3%
Q3 2020$36,007,000
+1.7%
2,018,318
+2.2%
0.01%
-12.5%
Q2 2020$35,398,000
+48.0%
1,974,155
+25.3%
0.01%
+14.3%
Q1 2020$23,923,000
+65.4%
1,575,982
+114.9%
0.01%
+133.3%
Q4 2019$14,467,000
+47.0%
733,248
+28.1%
0.00%0.0%
Q3 2019$9,843,000
-61.8%
572,243
-60.7%
0.00%
-57.1%
Q2 2019$25,743,000
-2.1%
1,454,409
+12.7%
0.01%0.0%
Q1 2019$26,294,000
+3914.4%
1,290,837
+3216.3%
0.01%
Q4 2018$655,00038,9240.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2019
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders